Genome biology · 2019 · 188 citations · 22 references
AgricultureCrop SciencesGeneticsGenome EditingPlant BiotechnologyPlant GeneticsCrispr-cas SystemsPlant Disease ResistancePlant Virus ReplicationPlant Virus ResistancePlant VirusesVirus EvolutionCrispr InterferenceCrispr-cas Systems In PlantsCrispr-cas9 Genome EditingDisease Resistance EngineeringMutagenic MechanismsViral Interference In PlantsVirus-resistant PlantsVirus-resistant Varieties
BACKGROUND: Geminiviruses cause damaging diseases in several important crop species. However, limited progress has been made in developing crop varieties resistant to these highly diverse DNA viruses. Recently, the bacterial CRISPR/Cas9 system has been transferred to plants to target and confer immunity to geminiviruses. In this study, we use CRISPR-Cas9 interference in the staple food crop cassava with the aim of engineering resistance to African cassava mosaic virus, a member of a widespread and important family (Geminiviridae) of plant-pathogenic DNA viruses. RESULTS: Our results show that the CRISPR system fails to confer effective resistance to the virus during glasshouse inoculations. Further, we find that between 33 and 48% of edited virus genomes evolve a conserved single-nucleotide mutation that confers resistance to CRISPR-Cas9 cleavage. We also find that in the model plant Nicotiana benthamiana the replication of the novel, mutant virus is dependent on the presence of the wild-type virus. CONCLUSIONS: Our study highlights the risks associated with CRISPR-Cas9 virus immunity in eukaryotes given that the mutagenic nature of the system generates viral escapes in a short time period. Our in-depth analysis of virus populations also represents a template for future studies analyzing virus escape from anti-viral CRISPR transgenics. This is especially important for informing regulation of such actively mutagenic applications of CRISPR-Cas9 technology in agriculture.
22
A Golden Gate Modular Cloning Toolbox for Plants
Carola Engler, Mark Youles, Ramona Gruetzner et al. · ACS Synthetic Biology · 2014 · 1K citations
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
David Bikard, Chad W. Euler, Wenyan Jiang et al. · Nature Biotechnology · 2014 · 970 citations · Full text